Immunoproteomic analysis of human serological antibody responses to vaccination with whole-cell pertussis vaccine (WCV)

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Zhu, Yong Zhang ^a,b   Cai, Cheng Song ^a   Zhang, Wei ^c   Guo, Hong Xiong ^d   Zhang, Jin Ping ^b   Ji, Ya Yong ^b   Ma, Guang Yuan ^b   Wu, Jia Lin ^b   Li, Qing Tian ^a   Lu, Cheng Ping ^c   Guo, Xiao Kui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Wuxi Center for Disease Prevention and Control   (China)

^c NANJING AGRICULTURAL UNIVERSITY   (China)

^d JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONIN; MEMBRANE PROTEIN; PERTACTIN; PERTUSSIS VACCINE; PORIN; PROTEOME; SUBUNIT VACCINE; ANTIBODY; BACTERIUM ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; BORDETELLA PERTUSSIS; CONTROLLED STUDY; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOBLOTTING; IMMUNOREACTIVITY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PERTUSSIS; SEROLOGY; TWO DIMENSIONAL ELECTROPHORESIS; WHOLE CELL; BLOOD; CHILD; IMMUNOLOGY; INFANT; METHODOLOGY; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BORDETELLA PERTUSSIS; MURINAE;

ANTIBODIES; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CHILD; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; IMMUNOBLOTTING; INFANT; PERTUSSIS VACCINE; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; WHOOPING COUGH;

EID: 78649729985     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013915     Document Type: Article

References (87)

1. WHO (2006) The world health report 2004 - changing history. World Health Organization.
2. Guiso N (2009) Bordetella pertussis and pertussis vaccines. Clin Infect Dis 49: 1565-1569.
3. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J (1996) A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 334: 349-355.
4. Tan T, Trindade E, Skowronski D (2005) Epidemiology of pertussis. Pediatr Infect Dis J 24: S10-18.
5. Das P (2002) Whooping cough makes global comeback. Lancet Infect Dis 2: 322.
6. Crowcroft NS, Pebody RG (2006) Recent developments in pertussis. Lancet 367: 1926-1936.
7. von Konig CH, Halperin S, Riffelmann M, Guiso N (2002) Pertussis of adults and infants. Lancet Infect Dis 2: 744-750.
8. Mattoo S, Cherry JD (2005) Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18: 326-382.
9. Elahi S, Brownlie R, Korzeniowski J, Buchanan R, O'Connor B, et al. (2005) Infection of newborn piglets with Bordetella pertussis: a new model for pertussis. Infect Immun 73: 3636-3645.
10. Woods DE, Franklin R, Cryz SJ, Jr., Ganss M, Peppler M, et al. (1989) Development of a rat model for respiratory infection with Bordetella pertussis. Infect Immun 57: 1018-1024.
11. Redhead K (1984) Serum antibody responses to the outer membrane proteins of Bordetella pertussis. Infect Immun 44: 724-729.
12. Ayalew S, Confer AW, Hartson SD, Shrestha B (2010) Immunoproteomic analyses of outer membrane proteins of Mannheimia haemolytica and identification of potential vaccine candidates. Proteomics 10: 2151-2164.
13. Li H, Ye MZ, Peng B, Wu HK, Xu CX, et al. (2010) Immunoproteomic identification of polyvalent vaccine candidates from Vibrio parahaemolyticus outer membrane proteins. J Proteome Res 9: 2573-2583.
14. Williams JN, Skipp PJ, O'Connor CD, Christodoulides M, Heckels JE (2009) Immunoproteomic analysis of the development of natural immunity in subjects colonized by Neisseria meningitidis reveals potential vaccine candidates. Infect Immun 77: 5080-5089.
15. Liao Y, Deng J, Zhang A, Zhou M, Hu Y, et al. (2009) Immunoproteomic analysis of outer membrane proteins and extracellular proteins of Actinobacillus pleuropneumoniae JL03 serotype 3. BMC Microbiol 9: 172.
16. Zhang W, Lu CP (2007) Immunoproteomic assay of membrane-associated proteins of Streptococcus suis type 2 China vaccine strain HA9801. Zoonoses Public Health 54: 253-259.
17. Leroy B, Roupie V, Noel-Georis I, Rosseels V, Walravens K, et al. (2007) Antigen discovery: a postgenomic approach to paratuberculosis diagnosis. Proteomics 7: 1164-1176.
18. Al Dahouk S, Nockler K, Scholz HC, Tomaso H, Bogumil R, et al. (2006) Immunoproteomic characterization of Brucella abortus 1119-3 preparations used for the serodiagnosis of Brucella infections. J Immunol Methods 309: 34-47.
19. Zhang W, Lu CP (2007) Immunoproteomics of extracellular proteins of Chinese virulent strains of Streptococcus suis type 2. Proteomics 7: 4468-4476.
20. Altindis E, Tefon BE, Yildirim V, Ozcengiz E, Becher D, et al. (2009) Immunoproteomic analysis of Bordetella pertussis and identification of new immunogenic proteins. Vaccine 27: 542-548.
21. Grandi G (2004) Genomics, Proteomics and Vaccines Grandi G, ed. Wiley.
22. Serruto D, Adu-Bobie J, Capecchi B, Rappuoli R, Pizza M, et al. (2004) Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens. J Biotechnol 113: 15-32.
23. Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, et al. (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287: 1816-1820.
24. Zhu YZ, Li QT, Wang L, Zhong Y, Ding GH, et al. (2008) Gene expression profiling-based in silico approach to identify potential vaccine candidates and drug targets against B. pertussis and B. parapertussis. OMICS 12: 161-169.
25. Bottero D, Gaillard ME, Fingermann M, Weltman G, Fernandez J, et al. (2007) Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin Vaccine Immunol 14: 1490-1498.
26. Roberts R, Moreno G, Bottero D, Gaillard ME, Fingermann M, et al. (2008) Outer membrane vesicles as acellular vaccine against pertussis. Vaccine 26: 4639-4646.
27. Cummings CA, Bootsma HJ, Relman DA, Miller JF (2006) Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. J Bacteriol 188: 1775-1785.
28. Redd SC, Rumschlag HS, Biellik RJ, Sanden GN, Reimer CB, et al. (1988) Immunoblot analysis of humoral immune responses following infection with Bordetella pertussis or immunization with diphtheria-tetanus-pertussis vaccine. J Clin Microbiol 26: 1373-1377.
29. Storsaeter J, Hallander HO, Gustafsson L, Olin P (1998) Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16: 1907-1916.
30. King AJ, Berbers G, van Oirschot HF, Hoogerhout P, Knipping K, et al. (2001) Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity. Microbiology 147: 2885-2895.
31. Cherry JD, Gornbein J, Heininger U, Stehr K (1998) A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16: 1901-1906.
32. Thomas MG, Redhead K, Lambert HP (1989) Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination. J Infect Dis 159: 211-218.
33. Charles IG, Li JL, Roberts M, Beesley K, Romanos M, et al. (1991) Identification and characterization of a protective immunodominant B cell epitope of pertactin (P.69) from Bordetella pertussis. Eur J Immunol 21: 1147-1153.
34. Oliver DC, Fernandez RC (2001) Antibodies to BrkA augment killing of Bordetella pertussis. Vaccine 20: 235-241.
35. Elder KD, Harvill ET (2004) Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract. Infect Immun 72: 5919-5924.
36. Armstrong SK, Parr TR, Jr., Parker CD, Hancock RE (1986) Bordetella pertussis major outer membrane porin protein forms small, anion-selective channels in lipid bilayer membranes. J Bacteriol 166: 212-216.
37. van Loo IH, Heuvelman KJ, King AJ, Mooi FR (2002) Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J Clin Microbiol 40: 1994-2001.
38. Poolman J, Hamstra HJ, Barlow A, Kuipers B, Loggen H, Nagel J (1990) Outer membrane vesicles of Bordetella pertussis are protective antigens in the mouse intracerebral challenge model. FDA. pp 202-206.
39. van den Berg BM, Beekhuizen H, Mooi FR, van Furth R (1999) Role of antibodies against Bordetella pertussis virulence factors in adherence of Bordetella pertussis and Bordetella parapertussis to human bronchial epithelial cells. Infect Immun 67: 1050-1055.
40. Deora R, Bootsma HJ, Miller JF, Cotter PA (2001) Diversity in the Bordetella virulence regulon: transcriptional control of a Bvg-intermediate phase gene. Mol Microbiol 40: 669-683.
41. Fuchslocher B, Millar LL, Cotter PA (2003) Comparison of bipA alleles within and across Bordetella species. Infect Immun 71: 3043-3052.
42. Borisova O, Kombarova SY, Zakharova NS, van Gent M, Aleshkin VA, et al. (2007) Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains. Clin Vaccine Immunol 14: 234-238.
43. Packard ER, Parton R, Coote JG, Fry NK (2004) Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J Med Microbiol 53: 355-365.
44. Del Giudice G, Gervaix A, Costantino P, Wyler CA, Tougne C, et al. (1993) Priming to heat shock proteins in infants vaccinated against pertussis. J Immunol 150: 2025-2032.
45. Johnson FD, Burns DL (1994) Detection and subcellular localization of three Ptl proteins involved in the secretion of pertussis toxin from Bordetella pertussis. J Bacteriol 176: 5350-5356.
46. Lopez JE, Siems WF, Palmer GH, Brayton KA, McGuire TC, et al. (2005) Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping. Infect Immun 73: 8109-8118.
47. Lopez JE, Porcella SF, Schrumpf ME, Raffel SJ, Hammer CH, et al. (2009) Identification of conserved antigens for early serodiagnosis of relapsing fever Borrelia. Microbiology 155: 2641-2651.
48. Sanchez-Campillo M, Bini L, Comanducci M, Raggiaschi R, Marzocchi B, et al. (1999) Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera. Electrophoresis 20: 2269-2279.
49. Chitlaru T, Gat O, Grosfeld H, Inbar I, Gozlan Y, et al. (2007) Identification of in vivo-expressed immunogenic proteins by serological proteome analysis of the Bacillus anthracis secretome. Infect Immun 75: 2841-2852.
50. Alam SI, Bansod S, Kumar RB, Sengupta N, Singh L (2009) Differential proteomic analysis of Clostridium perfringens ATCC13124; identification of dominant, surface and structure associated proteins. BMC Microbiol 9: 162.
51. Ying T, Wang H, Li M, Wang J, Shi Z, et al. (2005) Immunoproteomics of outer membrane proteins and extracellular proteins of Shigella flexneri 2a 2457T. Proteomics 5: 4777-4793.
52. Sellman BR, Howell AP, Kelly-Boyd C, Baker SM (2005) Identification of immunogenic and serum binding proteins of Staphylococcus epidermidis. Infect Immun 73: 6591-6600.
53. Janovska S, Pavkova I, Hubalek M, Lenco J, Macela A, et al. (2007) Identification of immunoreactive antigens in membrane proteins enriched fraction from Francisella tularensis LVS. Immunol Lett 108: 151-159.
54. Havlasova J, Hernychova L, Brychta M, Hubalek M, Lenco J, et al. (2005) Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia. Proteomics 5: 2090-2103.
55. Twine SM, Petit MD, Shen H, Mykytczuk NC, Kelly JF, et al. (2006) Immunoproteomic analysis of the murine antibody response to successful and failed immunization with live anti-Francisella vaccines. Biochem Biophys Res Commun 346: 999-1008.
56. Boonjakuakul JK, Gerns HL, Chen YT, Hicks LD, Minnick MF, et al. (2007) Proteomic and immunoblot analyses of Bartonella quintana total membrane proteins identify antigens recognized by sera from infected patients. Infect Immun 75: 2548-2561.
57. Granato D, Bergonzelli GE, Pridmore RD, Marvin L, Rouvet M, et al. (2004) Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins. Infect Immun 72: 2160-2169.
58. Balasubramanian S, Kannan TR, Baseman JB (2008) The surface-exposed carboxyl region of Mycoplasma pneumoniae elongation factor Tu interacts with fibronectin. Infect Immun 76: 3116-3123.
59. Kunert A, Losse J, Gruszin C, Huhn M, Kaendler K, et al. (2007) Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein. J Immunol 179: 2979-2988.
60. Vytvytska O, Nagy E, Bluggel M, Meyer HE, Kurzbauer R, et al. (2002) Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis. Proteomics 2: 580-590.
61. Delvecchio VG, Connolly JP, Alefantis TG, Walz A, Quan MA, et al. (2006) Proteomic profiling and identification of immunodominant spore antigens of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis. Appl Environ Microbiol 72: 6355-6363.
62. Gupta MK, Subramanian V, Yadav JS (2009) Immunoproteomic identification of secretory and subcellular protein antigens and functional evaluation of the secretome fraction of Mycobacterium immunogenum, a newly recognized species of the Mycobacterium chelonae-Mycobacterium abscessus group. J Proteome Res 8: 2319-2330.
63. da Fonseca CA, Jesuino RS, Felipe MS, Cunha DA, Brito WA, et al. (2001) Two-dimensional electrophoresis and characterization of antigens from Paracoccidioides brasiliensis. Microbes Infect 3: 535-542.
64. Shin GW, Nho SW, Park SB, Jang HB, Cha IS, et al. (2009) Comparison of antigenic proteins from Lactococcus garvieae KG- and KG+ strains that are recognized by olive flounder (Paralichthys olivaceus) antibodies. Vet Microbiol 139: 113-120.
65. Ling E, Feldman G, Portnoi M, Dagan R, Overweg K, et al. (2004) Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clin Exp Immunol 138: 290-298.
66. Pitarch A, Jimenez A, Nombela C, Gil C (2006) Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses. Mol Cell Proteomics 5: 79-96.
67. Pitarch A, Abian J, Carrascal M, Sanchez M, Nombela C, et al. (2004) Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies. Proteomics 4: 3084-3106.
68. Yan F, Xu L, Liu L, Yan R, Song X, et al. (2009) Immunoproteomic analysis of whole proteins from male and female adult Haemonchus contortus. Vet J.
69. Cole JN, Ramirez RD, Currie BJ, Cordwell SJ, Djordjevic SP, et al. (2005) Surface analyses and immune reactivities of major cell wall-associated proteins of group a streptococcus. Infect Immun 73: 3137-3146.
70. Argiro LL, Kohlstadt SS, Henri SS, Dessein HH, Matabiau VV, et al. (2000) Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH. Vaccine 18: 2039-2048.
71. Kawai K, Liu Y, Ohnishi K, Oshima S (2004) A conserved 37 kDa outer membrane protein of Edwardsiella tarda is an effective vaccine candidate. Vaccine 22: 3411-3418.
72. Erttmann KD, Kleensang A, Schneider E, Hammerschmidt S, Buttner DW, et al. (2005) Cloning, characterization and DNA immunization of an Onchocerca volvulus glyceraldehyde-3-phosphate dehydrogenase (Ov-GAPDH). Biochim Biophys Acta 1741: 85-94.
73. Peng X, Ye X, Wang S (2004) Identification of novel immunogenic proteins of Shigella flexneri 2a by proteomic methodologies. Vaccine 22: 2750-2756.
74. Teixeira-Gomes AP, Cloeckaert A, Bezard G, Bowden RA, Dubray G, et al. (1997) Identification and characterization of Brucella ovis immunogenic proteins using two-dimensional electrophoresis and immunoblotting. Electrophoresis 18: 1491-1497.
75. Graham JE, Clark-Curtiss JE (1999) Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS). Proc Natl Acad Sci U S A 96: 11554-11559.
76. Salim KY, Cvitkovitch DG, Chang P, Bast DJ, Handfield M, et al. (2005) Identification of group A Streptococcus antigenic determinants upregulated in vivo. Infect Immun 73: 6026-6038.
77. Lau GW, Haataja S, Lonetto M, Kensit SE, Marra A, et al. (2001) A functional genomic analysis of type 3 Streptococcus pneumoniae virulence. Mol Microbiol 40: 555-571.
78. Jones AL, Mertz RH, Carl DJ, Rubens CE (2007) A streptococcal penicillin-binding protein is critical for resisting innate airway defenses in the neonatal lung. J Immunol 179: 3196-3202.
79. Xia XX, Han MJ, Lee SY, Yoo JS (2008) Comparison of the extracellular proteomes of Escherichia coli B and K-12 strains during high cell density cultivation. Proteomics 8: 2089-2103.
80. Vidakovics ML, Paba J, Lamberti Y, Ricart CA, de Sousa MV, et al. (2007) Profiling the Bordetella pertussis proteome during iron starvation. J Proteome Res 6: 2518-2528.
81. Litt DJ, Savino S, Beddek A, Comanducci M, Sandiford C, et al. (2004) Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease. J Infect Dis 190: 1488-1497.
82. McKevitt M, Brinkman MB, McLoughlin M, Perez C, Howell JK, et al. (2005) Genome scale identification of Treponema pallidum antigens. Infect Immun 73: 4445-4450.
83. Cooney BJ, Lo RY (1993) Three contiguous lipoprotein genes in Pasteurella haemolytica A1 which are homologous to a lipoprotein gene in Haemophilus influenzae type b. Infect Immun 61: 4682-4688.
84. Bumann D, Holland P, Siejak F, Koesling J, Sabarth N, et al. (2002) A comparison of murine and human immunoproteomes of Helicobacter pylori validates the preclinical murine infection model for antigen screening. Infect Immun 70: 6494-6498.
85. Brinig MM, Cummings CA, Sanden GN, Stefanelli P, Lawrence A, et al. (2006) Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation. J Bacteriol 188: 2375-2382.
86. Bouchez V, Caro V, Levillain E, Guigon G, Guiso N (2008) Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination. PLoS One 3: e2437.
87. Caro V, Bouchez V, Guiso N (2008) Is the Sequenced Bordetella pertussis strain Tohama I representative of the species? J Clin Microbiol 46: 2125-2128.